Ivosidenib Impurity 14 | CAS 791061-00-2 - Request Quote
Ivosidenib Impurity 14
| SZ CAT No: | SZ-I026021 |
| CAS No | 791061-00-2 |
| Mol.F. | C4H7F2N |
| Mol.Wt. | 107.1 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 637031-93-7 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ivosidenib Impurity 14 is chemically 3,3-Difluorocyclobutan-1-amine. Ivosidenib Impurity 14 is supplied with detailed characterization data compliant with regulatory guideline. Ivosidenib Impurity 14 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ivosidenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 791061-00-2
Purchase 791061-00-2
Order 791061-00-2
Enquire 791061-00-2
price of 791061-00-2
791061-00-2 Supplier
791061-00-2 Manufacturer
791061-00-2 Exporter
buy high quality Ivosidenib Impurity 14
Purchase Ivosidenib Impurity 14
Ivosidenib Impurity 14 suppliers
Ivosidenib Impurity 14 manufacturers
Ivosidenib Impurity 14 price
Order Ivosidenib Impurity 14
Enquire Ivosidenib Impurity 14
Ivosidenib Impurity 14 cost
Ivosidenib Impurity 14 Supplier
Ivosidenib Impurity 14 Distributor
Ivosidenib Impurity 14 for Method Validation
Ivosidenib Reference Standard
Ivosidenib Impurity 14 for ANDA Filing
Ivosidenib Impurity 14 for Forced Degradation Studies
Ivosidenib Impurity 14 Identification Standards
Ivosidenib Impurity 14 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.